AGIOS PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
AGIOS PHARMACEUTICALS, INC. (AGIO) had Property, Plant and Equipment, Gross of $70.89 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-12
- 2025-12-31: Property, Plant and Equipment, Gross $70.89M.
- 2024-12-31: Property, Plant and Equipment, Gross $68.17M.
- 2023-12-31: Property, Plant and Equipment, Gross $67.61M.
- 2022-12-31: Property, Plant and Equipment, Gross $73.06M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $70.89M 10-K · filed 2026-02-12 | |
| 2024-12-31 | $68.17M 10-K · filed 2026-02-12 | |
| 2023-12-31 | $67.61M 10-K · filed 2025-02-13 | |
| 2022-12-31 | $73.06M 10-K · filed 2024-02-15 | |
| 2021-12-31 | $73.90M 10-K · filed 2023-02-23 | |
| 2020-12-31 | $72.17M 10-K · filed 2022-02-24 | $73.64M 10-K · filed 2021-02-25 |
| 2019-12-31 | $63.58M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $50.47M 10-K · filed 2020-02-19 | |
| 2017-12-31 | $43.83M 10-K · filed 2019-02-14 | |
| 2016-12-31 | $38.71M 10-K · filed 2018-02-14 | |
| 2015-12-31 | $30.88M 10-K · filed 2017-02-16 | |
| 2014-12-31 | $11.94M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $7.95M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $6.32M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |